Inducing autophagy (fasting, caloric restriction, exercise) extends lifespan in multiple model organisms; blocking it shortens it.
View the study (preclinical) →The accumulation of misfolded proteins (β-amyloid, tau, α-synuclein) that defines these diseases occurs in part because autophagy does not clear them efficiently.
View the study (review) →Macrophages need functional autophagy to eliminate intracellular pathogens (xenophagy) efficiently.
View the study (review) →⏱ 3 min read
Autophagy is one of those biological mechanisms that you only come to appreciate fully when you understand what your body would do without it: it would be like living in a house where the trash is never taken out, broken appliances are never repaired, and air filters are never cleaned; at first the buildup would be tolerable, but over time the deterioration becomes inevitable, and that is exactly what happens in cells when autophagy fails, something that occurs progressively with age.
The term autophagy comes from the Greek and literally means "self-eating," a description that, although it sounds alarming, is perfectly suited to what happens: the cell identifies its own damaged or obsolete components, including misfolded proteins, dysfunctional organelles, and intracellular pathogens, encapsulates them within vesicles called autophagosomes, and sends them for degradation, recovering the building blocks they contain so they can be recycled into the synthesis of new functional cellular components.
Basal autophagy is the non-selective form that operates continuously as a general maintenance program; it is active at baseline levels under normal nutrition conditions and increases dramatically in response to several types of cellular stress, with fasting being the most potent and best-studied inducer of all, followed by intense physical exercise; when nutrient sensors such as mTOR detect a drop in amino acid, glucose, and insulin levels, they turn off their inhibitory signals on autophagy and the process speeds up markedly.
Selective autophagy, for its part, is a precision program that targets specific types of cargo: mitophagy removes damaged mitochondria, a process of critical importance because deteriorated mitochondria produce excessive amounts of reactive oxygen species that damage DNA and other cellular structures; xenophagy targets intracellular pathogens such as bacteria and viruses; and other selective forms clear accumulations of lipids, fragments of endoplasmic reticulum, or other specific components.
The connection between autophagy and aging is one of the most robust in the biology of aging: in multiple model organisms, from yeast and worms to flies and mice, increasing autophagic activity extends lifespan, while blocking it shortens it; in humans, direct evidence is harder to obtain, but epidemiological studies show that practices that induce autophagy, such as caloric restriction, intermittent fasting, and regular exercise, are consistently associated with greater longevity and a lower incidence of age-related diseases.
The 2016 Nobel Prize in Physiology or Medicine was awarded to Yoshinori Ohsumi precisely for his discoveries on the mechanisms of autophagy, a recognition that reflects the central importance of this process in the modern understanding of cell biology and aging; his work in yeast identified the ATG genes that control the process and established the molecular foundation on which all subsequent research in more complex organisms has been built.
The relationship between autophagy and disease is not simple: in the context of cancer, for example, autophagy can act as a tumor suppressor in the early stages, preventing the accumulation of genomic damage and dysfunctional organelles that facilitate malignant transformation, but it can become a survival strategy for established tumor cells, which use it to tolerate the metabolic stress of the tumor microenvironment; this duality explains why some cancer treatments seek to activate autophagy and others seek to inhibit it, depending on the stage and type of tumor.
In neurodegenerative diseases such as Parkinson's and Alzheimer's, failures in autophagy are a constant feature: the accumulation of misfolded proteins that is the signature of these diseases, alpha-synuclein in Parkinson's, tau and beta-amyloid in Alzheimer's, occurs in part because autophagy cannot clear them with the necessary efficiency; this vicious circle in which more accumulated proteins further impair the cell's degradation mechanisms is one of the reasons why pharmacological or behavioral modulation of autophagy has generated so much interest as a possible therapeutic strategy.
Information, not medical advice. Scientific evidence reflects the quality of the studies.